Defibrillator Devices Global Market - Forecast to 2023
Defibrillator devices are class of medical devices used for delivering shock in a controlled and automated manner. These devices are mainly used for therapeutic purposes in cardiovascular critical care management, where electrical shock is required to convert patient’s abnormal heart rhythm into normal heart rhythm to revive the victim of sudden cardiac arrest. These defibrillators help in saving the life of a SCA victim, who would have few minutes lifeline and requires resuscitation to avoid situations, which would lead to serious life threatening circumstances or even sometimes to death of a patient.
Defibrillator devices market is segmented on the basis of products, applications, end-users and geography. Products are segmented into devices, consumables and servicing, whereas devices are further segmented into Implantable Cardioverter Defibrillators (ICD’s) and external defibrillators. Implantable cardioverter defibrillators are further segmented into Transvenous Implantable Cardioverter Defibrillators (T-ICD’s) and Subcutaneous Implantable Cardioverter Defibrillators (S-ICD’s), similarly external defibrillators are classified into Automated External Defibrillators (AED’s), Wearable cardioverter defibrillators and Advanced Life Support Defibrillators (ALS). Consumables are further segmented into electrode pads, battery & chargers, first aid kits and supplies/rescue kits and others including cables & data cables, carry cases or backpacks, training units, training manikins and cabinets Applications are segmented into ventricular fibrillation, ventricular tachycardia and bradycardia. End-users are further classified into hospitals, ambulatory surgical centers, homecare, public access care, pre-hospitals and others (clinics & cardiac centers & alternative care centers).
According to IQ4I analysis, the defibrillator devices global market is expected to grow at a mid to high single digit CAGR to reach $17,710.8 million by 2023. Among the defibrillator devices products market implantable cardioverter defibrillators segment holds the largest share of the market and external defibrillators is expected to be the fastest growing segment. In applications market ventricular tachycardia holds the largest share of the market and ventricular fibrillation is expected to grow with a strong CAGR from 2016 to 2023. In end- users, hospitals are the largest segment and home healthcare is the fastest growing segment from 2016 to 2023. Geographically, North America is the largest market followed by Europe and Asia Pacific. The APAC region is the fastest growing region from 2016 to 2023 presenting an array of opportunities for growth and is likely to get attention of new investors in the defibrillator devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The defibrillator devices market is expected to grow at a single high digit CAGR during 2016 to 2023. Increase in aging population and subsequent rise in incidence of cardiovascular diseases, increasing use of defibrillators in public access areas and favorable reimbursement policies are the factors driving the market growth. Increasing trend of MRI compatible defibrillators, emergence of next generation integrated ICD’s and market expansion opportunities in emerging nations are expected to offer potential opportunities.
However various factors like patient safety risks due to chances of infection and other complications while using defibrillators, lack of awareness on sudden cardiac arrests limit the growth of defibrillator devices global market. The threats for the defibrillator devices market include lack of cybersecurity in ICD’s and increasing number of defibrillator device recalls due to FDA mandates.
The defibrillator devices global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the defibrillator devices market are Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Asahi Kasei Corporation (Japan), Medtronic PLC (Ireland), Philips Healthcare (Netherland), Biotronik Se & Co. Kg (Germany), Stryker Corporation (U.S.), LivaNova (U.K.) and Nihon Kohden Corporation (Japan).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
Defibrillator devices market is segmented on the basis of products, applications, end-users and geography. Products are segmented into devices, consumables and servicing, whereas devices are further segmented into Implantable Cardioverter Defibrillators (ICD’s) and external defibrillators. Implantable cardioverter defibrillators are further segmented into Transvenous Implantable Cardioverter Defibrillators (T-ICD’s) and Subcutaneous Implantable Cardioverter Defibrillators (S-ICD’s), similarly external defibrillators are classified into Automated External Defibrillators (AED’s), Wearable cardioverter defibrillators and Advanced Life Support Defibrillators (ALS). Consumables are further segmented into electrode pads, battery & chargers, first aid kits and supplies/rescue kits and others including cables & data cables, carry cases or backpacks, training units, training manikins and cabinets Applications are segmented into ventricular fibrillation, ventricular tachycardia and bradycardia. End-users are further classified into hospitals, ambulatory surgical centers, homecare, public access care, pre-hospitals and others (clinics & cardiac centers & alternative care centers).
According to IQ4I analysis, the defibrillator devices global market is expected to grow at a mid to high single digit CAGR to reach $17,710.8 million by 2023. Among the defibrillator devices products market implantable cardioverter defibrillators segment holds the largest share of the market and external defibrillators is expected to be the fastest growing segment. In applications market ventricular tachycardia holds the largest share of the market and ventricular fibrillation is expected to grow with a strong CAGR from 2016 to 2023. In end- users, hospitals are the largest segment and home healthcare is the fastest growing segment from 2016 to 2023. Geographically, North America is the largest market followed by Europe and Asia Pacific. The APAC region is the fastest growing region from 2016 to 2023 presenting an array of opportunities for growth and is likely to get attention of new investors in the defibrillator devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The defibrillator devices market is expected to grow at a single high digit CAGR during 2016 to 2023. Increase in aging population and subsequent rise in incidence of cardiovascular diseases, increasing use of defibrillators in public access areas and favorable reimbursement policies are the factors driving the market growth. Increasing trend of MRI compatible defibrillators, emergence of next generation integrated ICD’s and market expansion opportunities in emerging nations are expected to offer potential opportunities.
However various factors like patient safety risks due to chances of infection and other complications while using defibrillators, lack of awareness on sudden cardiac arrests limit the growth of defibrillator devices global market. The threats for the defibrillator devices market include lack of cybersecurity in ICD’s and increasing number of defibrillator device recalls due to FDA mandates.
The defibrillator devices global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the defibrillator devices market are Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Asahi Kasei Corporation (Japan), Medtronic PLC (Ireland), Philips Healthcare (Netherland), Biotronik Se & Co. Kg (Germany), Stryker Corporation (U.S.), LivaNova (U.K.) and Nihon Kohden Corporation (Japan).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in aging population and subsequent rise in incidence of cardiovascular diseases
3.3.1.2 Increasing use of defibrillators in public access areas
3.3.1.3 Favorable reimbursement policies
3.3.1.4 Emergence of next generation integrated ICD’s
3.3.1.5 Increasing trend for MRI compatible defibrillators
3.3.1.6 Market expansion opportunities in emerging nations
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Patient safety risks due to chances of infections and other complications while using defibrillators
3.3.2.2 Lack of awareness on sudden cardiac arrests
3.3.2.3 Lack of cybersecurity in ICD’s
3.3.2.4 Increasing number of defibrillator devices product recalls due to FDA mandates
3.4 REIMBURSEMENT SCENARIO
3.4.1 REIMBURSEMENT TABLE
3.5 REGULATORY AFFAIRS
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 INDIA
3.5.4 CHINA
3.5.5 JAPAN
3.6 TECHNOLOGICAL ADVANCEMENTS AND ON GOING CLINICAL TRIALS
3.6.1 NEXT GENERATION ICD’s
3.6.2 CUSTOMIZED DEFIBRILLATOR DEVICES & CONSUMABLES
3.6.3 LEADLESS DEFIBRILLATORS
3.6.4 3D PRINTED MULTIFUNCTIONAL INTEGUMENTARY MEMBRANE DEVICES (MIM) FOR ARRYTHMIAS DIAGNOSIS
3.6.5 AMBULANCE DRONE
3.6.6 AMBULANCE ROBOTIC ASSISTED AED’s IN SMART CITIES
3.6.7 DEFIBRILLATOR DEVICES UNDER CLINICAL TRIAL
3.7 MODE OF OPERATION
3.7.1 EXTERNAL MODE OF OPERATION
3.7.2 INTERNAL MODE OF OPERATION
3.7.3 SYNCHRONIZED MODE OF OPERATION
3.8 PATENT ANALYSIS
3.9 SUPPLY CHAIN ANALYSIS
3.10 PORTER’S FIVE FORCE ANALYSIS
3.10.1 THREAT OF NEW ENTRANTS
3.10.2 THREAT OF SUBSTITUTES
3.10.3 RIVALRY AMONG EXISTING COMPETITORS
3.10.4 BARGAINING POWER OF SUPPLIERS
3.10.5 BARGAINING POWER OF BUYERS
3.11 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR V/S EXTERNAL DEFIBRILLATOR DEVICES
3.12 MARKET SHARE ANALYSIS
3.12.1 DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS
3.12.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR GLOBAL MARKET SHARE ANALYSIS
3.12.3 AUTOMATED EXTERNAL DEFIBRILLATORS GLOBAL MARKET SHARE ANALYSIS
3.12.4 ADVANCED LIFE SUPPORT (ALS) DEFIBRILLATORS GLOBAL MARKET SHARE ANALYSIS
4 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 DEVICES
4.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD’S)
4.2.1.1 Transvenous Implantable Cardioverter Defibrillators (T-ICD’s)
4.2.1.1.1 Biventricular ICD’s/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
4.2.1.1.2 Dual Chamber ICD’s
4.2.1.1.3 Single Chamber ICD’s
4.2.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICD’s)
4.2.2 EXTERNAL DEFIBRILLATORS
4.2.2.1 Automated External Defibrillators (AEDs)
4.2.2.1.1 Semi-Automated AEDs
4.2.2.1.2 Fully Automated AED’s
4.2.2.2 Wearable Cardioverter Defibrillators (WCD)/ Wearable External Defibrillators (WED)
4.2.2.3 Advanced Life Support Defibrillators (ALS)
4.3 CONSUMABLES
4.4 SERVICING
5 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY APPLICATIONS
5.1 INTRODUCTION
5.2 VENTRICULAR TACHYCARDIA
5.3 VENTRICULAR FIBRILLATION
5.4 BRADYCARDIA
6 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 HOME HEALTHCARE PROVIDERS
6.4 AMBULATORY SURGICAL CENTERS
6.5 PUBLIC ACCESS CARE
6.6 PRE-HOSPITAL CARE
6.7 OTHERS
7 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY GEOGRAPHY
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 UNITED STATES (U.S.)
7.2.2 OTHERS
7.3 EUROPE
7.3.1 FRANCE
7.3.2 ITALY
7.3.3 GERMANY
7.3.4 OTHERS
7.4 ASIA-PACIFIC (APAC)
7.4.1 INDIA
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 OTHERS
7.5 REST OF WORLD (ROW)
7.5.1 BRAZIL
7.5.2 REST OF LATIN AMERICA
7.5.3 MIDDLE EAST & OTHERS
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.1.1 APPROVAL AS A MAJOR GROWTH STRATEGY OF DEFIBRILLATOR DEVICES PLAYERS
8.2 APPROVALS
8.3 NEW PRODUCT LAUNCH
8.4 OTHER DEVELOPMENTS
8.5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
8.6 MERGERS & ACQUISITIONS
9 COMPANY PROFILES
9.1 ABBOTT LABORATORIES, INC (ST JUDE MEDICAL, INC.)
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 ASAHI KASEI CORPORATION (ZOLL MEDICAL CORPORATION)
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 AURORA CAPITAL GROUP (CARDIAC SCIENCE CORPORATION)
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 BOSTON SCIENTIFIC CORPORATION
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 BIOTRONIK SE & CO.KG
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 LIVANOVA (SORIN GROUP)
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 MEDTRONIC PLC
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 NIHON KOHDEN CORPORATION
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 PHILIPS HEALTHCARE
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 STRYKER CORPORATION
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in aging population and subsequent rise in incidence of cardiovascular diseases
3.3.1.2 Increasing use of defibrillators in public access areas
3.3.1.3 Favorable reimbursement policies
3.3.1.4 Emergence of next generation integrated ICD’s
3.3.1.5 Increasing trend for MRI compatible defibrillators
3.3.1.6 Market expansion opportunities in emerging nations
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Patient safety risks due to chances of infections and other complications while using defibrillators
3.3.2.2 Lack of awareness on sudden cardiac arrests
3.3.2.3 Lack of cybersecurity in ICD’s
3.3.2.4 Increasing number of defibrillator devices product recalls due to FDA mandates
3.4 REIMBURSEMENT SCENARIO
3.4.1 REIMBURSEMENT TABLE
3.5 REGULATORY AFFAIRS
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 INDIA
3.5.4 CHINA
3.5.5 JAPAN
3.6 TECHNOLOGICAL ADVANCEMENTS AND ON GOING CLINICAL TRIALS
3.6.1 NEXT GENERATION ICD’s
3.6.2 CUSTOMIZED DEFIBRILLATOR DEVICES & CONSUMABLES
3.6.3 LEADLESS DEFIBRILLATORS
3.6.4 3D PRINTED MULTIFUNCTIONAL INTEGUMENTARY MEMBRANE DEVICES (MIM) FOR ARRYTHMIAS DIAGNOSIS
3.6.5 AMBULANCE DRONE
3.6.6 AMBULANCE ROBOTIC ASSISTED AED’s IN SMART CITIES
3.6.7 DEFIBRILLATOR DEVICES UNDER CLINICAL TRIAL
3.7 MODE OF OPERATION
3.7.1 EXTERNAL MODE OF OPERATION
3.7.2 INTERNAL MODE OF OPERATION
3.7.3 SYNCHRONIZED MODE OF OPERATION
3.8 PATENT ANALYSIS
3.9 SUPPLY CHAIN ANALYSIS
3.10 PORTER’S FIVE FORCE ANALYSIS
3.10.1 THREAT OF NEW ENTRANTS
3.10.2 THREAT OF SUBSTITUTES
3.10.3 RIVALRY AMONG EXISTING COMPETITORS
3.10.4 BARGAINING POWER OF SUPPLIERS
3.10.5 BARGAINING POWER OF BUYERS
3.11 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR V/S EXTERNAL DEFIBRILLATOR DEVICES
3.12 MARKET SHARE ANALYSIS
3.12.1 DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS
3.12.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR GLOBAL MARKET SHARE ANALYSIS
3.12.3 AUTOMATED EXTERNAL DEFIBRILLATORS GLOBAL MARKET SHARE ANALYSIS
3.12.4 ADVANCED LIFE SUPPORT (ALS) DEFIBRILLATORS GLOBAL MARKET SHARE ANALYSIS
4 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 DEVICES
4.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD’S)
4.2.1.1 Transvenous Implantable Cardioverter Defibrillators (T-ICD’s)
4.2.1.1.1 Biventricular ICD’s/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
4.2.1.1.2 Dual Chamber ICD’s
4.2.1.1.3 Single Chamber ICD’s
4.2.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICD’s)
4.2.2 EXTERNAL DEFIBRILLATORS
4.2.2.1 Automated External Defibrillators (AEDs)
4.2.2.1.1 Semi-Automated AEDs
4.2.2.1.2 Fully Automated AED’s
4.2.2.2 Wearable Cardioverter Defibrillators (WCD)/ Wearable External Defibrillators (WED)
4.2.2.3 Advanced Life Support Defibrillators (ALS)
4.3 CONSUMABLES
4.4 SERVICING
5 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY APPLICATIONS
5.1 INTRODUCTION
5.2 VENTRICULAR TACHYCARDIA
5.3 VENTRICULAR FIBRILLATION
5.4 BRADYCARDIA
6 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 HOME HEALTHCARE PROVIDERS
6.4 AMBULATORY SURGICAL CENTERS
6.5 PUBLIC ACCESS CARE
6.6 PRE-HOSPITAL CARE
6.7 OTHERS
7 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY GEOGRAPHY
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 UNITED STATES (U.S.)
7.2.2 OTHERS
7.3 EUROPE
7.3.1 FRANCE
7.3.2 ITALY
7.3.3 GERMANY
7.3.4 OTHERS
7.4 ASIA-PACIFIC (APAC)
7.4.1 INDIA
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 OTHERS
7.5 REST OF WORLD (ROW)
7.5.1 BRAZIL
7.5.2 REST OF LATIN AMERICA
7.5.3 MIDDLE EAST & OTHERS
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.1.1 APPROVAL AS A MAJOR GROWTH STRATEGY OF DEFIBRILLATOR DEVICES PLAYERS
8.2 APPROVALS
8.3 NEW PRODUCT LAUNCH
8.4 OTHER DEVELOPMENTS
8.5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
8.6 MERGERS & ACQUISITIONS
9 COMPANY PROFILES
9.1 ABBOTT LABORATORIES, INC (ST JUDE MEDICAL, INC.)
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 ASAHI KASEI CORPORATION (ZOLL MEDICAL CORPORATION)
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 AURORA CAPITAL GROUP (CARDIAC SCIENCE CORPORATION)
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 BOSTON SCIENTIFIC CORPORATION
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 BIOTRONIK SE & CO.KG
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 LIVANOVA (SORIN GROUP)
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 MEDTRONIC PLC
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 NIHON KOHDEN CORPORATION
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 PHILIPS HEALTHCARE
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 STRYKER CORPORATION
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 2 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 3 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 4 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 5 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 6 DEVICES DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 7 DEVICES DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 8 AVERAGE SELLING PRICE ($) OF DEFIBRILLATOR DEVICES, BY TYPES
TABLE 9 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 10 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 11 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 12 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 13 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 14 BIVENTRICULAR ICD’S/CRT-D’S DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 15 BIVENTRICULAR ICD’S/CRT-D’S DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 16 DUAL CHAMBER ICD’S DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 17 DUAL CHAMBER ICD’S DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 18 SINGLE CHAMBER ICD’S DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 19 SINGLE CHAMBER ICD’S DEVICES NO. OF UNITS, BY REGION (2015-2023) ($MN)
TABLE 20 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEVICES GLOBAL MARKET REVENUE BY REGION (2015-2023) ($MN)
TABLE 21 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 22 EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 23 EXTERNAL DEFIBRILLATORS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 24 AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 25 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 26 AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 27 SEMI-AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 28 FULLY AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 29 WEARABLE CARDIOVERTER DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 30 WEARABLE CARDIOVERTER DEFIBRILLATOR DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 31 ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 32 ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 33 CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 34 SERVICING GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 35 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 36 VENTRICULAR TACHYCARDIA DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 37 VENTRICULAR FIBRILLATION DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 38 BRADYCARDIA DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 39 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 40 HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 41 HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 42 AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 43 PUBLIC ACCESS CARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 44 PRE HOSPITAL CARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 45 OTHERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 46 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 47 NORTH AMERICAN BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 48 NORTH AMERICAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 49 NORTH AMERICAN TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 50 NORTH AMERICAN EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 51 NORTH AMERICAN AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 52 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 53 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 54 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 55 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 56 EUROPEAN BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 57 EUROPEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 58 EUROPEAN TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 59 EUROPEAN EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 60 EUROPEAN AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 61 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 62 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 63 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 64 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 65 ASIA PACIFIC BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 66 ASIA PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 67 ASIA PACIFIC TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 68 ASIA PACIFIC EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 69 ASIA PACIFIC AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 70 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 71 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 72 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 73 REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 74 REST OF THE WORLD BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 75 REST OF THE WORLD IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 76 REST OF THE WORLD TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 77 REST OF THE WORLD EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 78 REST OF THE WORLD AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 79 REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 80 REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 81 REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 82 APPROVALS,(2015-2016)
TABLE 83 NEW PRODUCT LAUNCHES,(2014-2017)
TABLE 84 OTHER DEVELOPMENTS (2015)
TABLE 85 AGREEMENTS & PARTNERSHIPS, (2015-2016)
TABLE 86 MERGERS AND ACQUISITIONS, (2016)
TABLE 87 ABBOTT LABORATORIES, INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 88 ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 89 ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 90 ASAHI KASEI CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 91 ASAHI KASEI CORPORATION: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
TABLE 92 ASAHI KASEI CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
TABLE 93 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 94 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 95 BOSTON SCIENTIFIC CORPORATION: RHYTHM MANAGEMENT REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 96 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 97 LIVANOVA, PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 98 LIVANOVA, PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 99 LIVANOVA, PLC: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 100 MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 101 MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
TABLE 102 MEDTRONIC PLC: TOTAL REVENUE, BY CARDIAC & VASCULAR GROUP SEGMENTS (2014-2016) ($MN)
TABLE 103 MEDTRONIC PLC: TOTAL REVENUE, BY REGIONS (2014-2016) ($MN)
TABLE 104 NIHON KOHDEN CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 105 NIHON KOHDEN CORPORATION: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
TABLE 106 NIHON KOHDEN CORPORATION: TOTAL REVENUE, BY REGIONS (2014-2016) ($MN)
TABLE 107 PHILIPS HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 108 PHILIPS HEALTHCARE: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
TABLE 109 PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 110 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 111 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 112 STRYKER CORPORATION: TOTAL REVENUE, BY MEDSURG SEGMENTS, (2014-2016) ($MN)
TABLE 113 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 1 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 2 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 3 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 4 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 5 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 6 DEVICES DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 7 DEVICES DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 8 AVERAGE SELLING PRICE ($) OF DEFIBRILLATOR DEVICES, BY TYPES
TABLE 9 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 10 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 11 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 12 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 13 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 14 BIVENTRICULAR ICD’S/CRT-D’S DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 15 BIVENTRICULAR ICD’S/CRT-D’S DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 16 DUAL CHAMBER ICD’S DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 17 DUAL CHAMBER ICD’S DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 18 SINGLE CHAMBER ICD’S DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 19 SINGLE CHAMBER ICD’S DEVICES NO. OF UNITS, BY REGION (2015-2023) ($MN)
TABLE 20 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEVICES GLOBAL MARKET REVENUE BY REGION (2015-2023) ($MN)
TABLE 21 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 22 EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 23 EXTERNAL DEFIBRILLATORS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 24 AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 25 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 26 AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 27 SEMI-AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 28 FULLY AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 29 WEARABLE CARDIOVERTER DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 30 WEARABLE CARDIOVERTER DEFIBRILLATOR DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 31 ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 32 ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
TABLE 33 CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 34 SERVICING GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 35 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 36 VENTRICULAR TACHYCARDIA DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 37 VENTRICULAR FIBRILLATION DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 38 BRADYCARDIA DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 39 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 40 HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 41 HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 42 AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 43 PUBLIC ACCESS CARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 44 PRE HOSPITAL CARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 45 OTHERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 46 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 47 NORTH AMERICAN BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 48 NORTH AMERICAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 49 NORTH AMERICAN TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 50 NORTH AMERICAN EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 51 NORTH AMERICAN AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 52 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 53 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 54 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 55 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 56 EUROPEAN BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 57 EUROPEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 58 EUROPEAN TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 59 EUROPEAN EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 60 EUROPEAN AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 61 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 62 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 63 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 64 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 65 ASIA PACIFIC BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 66 ASIA PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 67 ASIA PACIFIC TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 68 ASIA PACIFIC EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 69 ASIA PACIFIC AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 70 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 71 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 72 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 73 REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 74 REST OF THE WORLD BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 75 REST OF THE WORLD IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 76 REST OF THE WORLD TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 77 REST OF THE WORLD EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 78 REST OF THE WORLD AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
TABLE 79 REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
TABLE 80 REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 81 REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 82 APPROVALS,(2015-2016)
TABLE 83 NEW PRODUCT LAUNCHES,(2014-2017)
TABLE 84 OTHER DEVELOPMENTS (2015)
TABLE 85 AGREEMENTS & PARTNERSHIPS, (2015-2016)
TABLE 86 MERGERS AND ACQUISITIONS, (2016)
TABLE 87 ABBOTT LABORATORIES, INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 88 ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 89 ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 90 ASAHI KASEI CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 91 ASAHI KASEI CORPORATION: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
TABLE 92 ASAHI KASEI CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
TABLE 93 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 94 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 95 BOSTON SCIENTIFIC CORPORATION: RHYTHM MANAGEMENT REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 96 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 97 LIVANOVA, PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 98 LIVANOVA, PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 99 LIVANOVA, PLC: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 100 MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 101 MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
TABLE 102 MEDTRONIC PLC: TOTAL REVENUE, BY CARDIAC & VASCULAR GROUP SEGMENTS (2014-2016) ($MN)
TABLE 103 MEDTRONIC PLC: TOTAL REVENUE, BY REGIONS (2014-2016) ($MN)
TABLE 104 NIHON KOHDEN CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 105 NIHON KOHDEN CORPORATION: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
TABLE 106 NIHON KOHDEN CORPORATION: TOTAL REVENUE, BY REGIONS (2014-2016) ($MN)
TABLE 107 PHILIPS HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 108 PHILIPS HEALTHCARE: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
TABLE 109 PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 110 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 111 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 112 STRYKER CORPORATION: TOTAL REVENUE, BY MEDSURG SEGMENTS, (2014-2016) ($MN)
TABLE 113 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
LIST OF FIGURES
FIGURE 1 DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE AND REVENUE, BY REGION (2015-2023)
FIGURE 2 DEFIBRILLATOR DEVICES GLOBAL MARKET: RESEARCH APPROACH
FIGURE 3 DEFIBRILLATOR DEVICES GLOBAL MARKET: TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 DEFIBRILLATOR DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 DEFIBRILLATOR DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 DEFIBRILLATOR DEVICES GLOBAL MARKET: MARKET SEGMENTATION
FIGURE 7 DEFIBRILLATOR DEVICES GLOBAL MARKET: MARKET DYNAMICS
FIGURE 8 DEFIBRILLATOR DEVICES GLOBAL MARKET: PATENT FILING, BY MAJOR PLAYERS (2012-2016)
FIGURE 9 DEFRILLATOR DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 DEFIBRILLATOR DEVICES GLOBAL MARKET: PORTER’S FIVE FORCE ANALYSIS
FIGURE 11 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR V/S EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE, 2016 (%)
FIGURE 12 DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
FIGURE 13 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
FIGURE 14 AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
FIGURE 15 ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
FIGURE 16 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2016 V’S 2023) ($MN)
FIGURE 17 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY DEVICES, (2016 V’S 2023) ($MN)
FIGURE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
FIGURE 19 TRANSVENOUS IMPLANTABLE DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
FIGURE 20 EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
FIGURE 21 AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
FIGURE 22 AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE, BY END-USERS, 2016 (%)
FIGURE 23 ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE, BY END-USERS, 2016 (%)
FIGURE 24 DEFIBRILLATOR DEVICES GLOBAL MARKET SHARES, BY APPLICATIONS, (2016 V’S 2023) (%)
FIGURE 25 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2016 V’S 2023) ($MN)
FIGURE 26 DEFIBRILLATOR DEVICES GLOBAL MARKET SCENARIO, BY REGION, (2015-2023) ($MN) CAGR (%)
FIGURE 27 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS ($MN), & END-USERS (%), (2016 V’S 2023)
FIGURE 28 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 29 U.S. DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 30 U.S. DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 31 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 32 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 33 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 34 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 35 FRANCE DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 36 FRANCE DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 37 ITALY DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 38 ITALY DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 39 GERMANY DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 40 GERMANY DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 41 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 42 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 43 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 44 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 45 INDIA DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 46 INDIA DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 47 CHINA DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 48 CHINA DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 49 JAPAN DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 50 JAPAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 51 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 52 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 53 259REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 54 REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 55 BRAZIL DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 56 BRAZIL DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 57 REST OF LATIN AMERICA DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 58 REST OF LATIN AMERICA DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 59 MIDDLE EAST & OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 60 MIDDLE EAST & OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 61 KEY GROWTH STRATEGIES, (2014-2016)
FIGURE 62 SWOT: ABBOTT LABORATORIES (ST. JUDE MEDICAL, INC.)
FIGURE 63 SWOT: ASHAI KASEI CORPORATION (ZOLL MEDICAL CORPORATION)
FIGURE 64 SWOT: AURORA CAPITAL GROUP (CARDIAC SCIENCE CORPORATION)
FIGURE 65 SWOT: BOSTON SCIENTIFIC CORPORATION
FIGURE 66 SWOT: BIOTRONIK SE & CO.KG
FIGURE 67 SWOT: LIVANOVA, PLC (SORIN GROUP)
FIGURE 68 SWOT: MEDTRONIC PLC
FIGURE 69 SWOT: NIHON KHODEN CORPORATION (DEFIBTECH)
FIGURE 70 SWOT: PHILIPS HEALTHCARE
FIGURE 71 SWOT: PHYSIO CONTROL INC (STRYKER CORPORATION)
FIGURE 1 DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE AND REVENUE, BY REGION (2015-2023)
FIGURE 2 DEFIBRILLATOR DEVICES GLOBAL MARKET: RESEARCH APPROACH
FIGURE 3 DEFIBRILLATOR DEVICES GLOBAL MARKET: TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 DEFIBRILLATOR DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 DEFIBRILLATOR DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 DEFIBRILLATOR DEVICES GLOBAL MARKET: MARKET SEGMENTATION
FIGURE 7 DEFIBRILLATOR DEVICES GLOBAL MARKET: MARKET DYNAMICS
FIGURE 8 DEFIBRILLATOR DEVICES GLOBAL MARKET: PATENT FILING, BY MAJOR PLAYERS (2012-2016)
FIGURE 9 DEFRILLATOR DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 DEFIBRILLATOR DEVICES GLOBAL MARKET: PORTER’S FIVE FORCE ANALYSIS
FIGURE 11 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR V/S EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE, 2016 (%)
FIGURE 12 DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
FIGURE 13 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
FIGURE 14 AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
FIGURE 15 ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
FIGURE 16 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2016 V’S 2023) ($MN)
FIGURE 17 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY DEVICES, (2016 V’S 2023) ($MN)
FIGURE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
FIGURE 19 TRANSVENOUS IMPLANTABLE DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
FIGURE 20 EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
FIGURE 21 AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
FIGURE 22 AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE, BY END-USERS, 2016 (%)
FIGURE 23 ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE, BY END-USERS, 2016 (%)
FIGURE 24 DEFIBRILLATOR DEVICES GLOBAL MARKET SHARES, BY APPLICATIONS, (2016 V’S 2023) (%)
FIGURE 25 DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2016 V’S 2023) ($MN)
FIGURE 26 DEFIBRILLATOR DEVICES GLOBAL MARKET SCENARIO, BY REGION, (2015-2023) ($MN) CAGR (%)
FIGURE 27 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS ($MN), & END-USERS (%), (2016 V’S 2023)
FIGURE 28 NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 29 U.S. DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 30 U.S. DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 31 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 32 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 33 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 34 EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 35 FRANCE DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 36 FRANCE DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 37 ITALY DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 38 ITALY DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 39 GERMANY DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 40 GERMANY DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 41 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 42 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 43 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 44 ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 45 INDIA DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 46 INDIA DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 47 CHINA DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 48 CHINA DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 49 JAPAN DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 50 JAPAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 51 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 52 OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 53 259REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 54 REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 55 BRAZIL DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 56 BRAZIL DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 57 REST OF LATIN AMERICA DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 58 REST OF LATIN AMERICA DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 59 MIDDLE EAST & OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
FIGURE 60 MIDDLE EAST & OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
FIGURE 61 KEY GROWTH STRATEGIES, (2014-2016)
FIGURE 62 SWOT: ABBOTT LABORATORIES (ST. JUDE MEDICAL, INC.)
FIGURE 63 SWOT: ASHAI KASEI CORPORATION (ZOLL MEDICAL CORPORATION)
FIGURE 64 SWOT: AURORA CAPITAL GROUP (CARDIAC SCIENCE CORPORATION)
FIGURE 65 SWOT: BOSTON SCIENTIFIC CORPORATION
FIGURE 66 SWOT: BIOTRONIK SE & CO.KG
FIGURE 67 SWOT: LIVANOVA, PLC (SORIN GROUP)
FIGURE 68 SWOT: MEDTRONIC PLC
FIGURE 69 SWOT: NIHON KHODEN CORPORATION (DEFIBTECH)
FIGURE 70 SWOT: PHILIPS HEALTHCARE
FIGURE 71 SWOT: PHYSIO CONTROL INC (STRYKER CORPORATION)
